Straumann Holding AG (XSWX:STMN) 3-Year EPS without NRI Growth Rate : 19.50% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Straumann Holding AG 3-Year EPS without NRI Growth Rate?

Straumann Holding AG's EPS without NRI for the six months ended in Dec. 2023 was CHF1.33.

During the past 12 months, Straumann Holding AG's average EPS without NRI Growth Rate was -8.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 19.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Straumann Holding AG was 109.80% per year. The lowest was -60.10% per year. And the median was 19.50% per year.

Competitive Comparison of Straumann Holding AG's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's 3-Year EPS without NRI Growth Rate falls into.

Straumann Holding AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Straumann Holding AG (XSWX:STMN) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Straumann Holding AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (XSWX:STMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (XSWX:STMN) Headlines

No Headlines